iBiOME
Latest round
- Angel
Last raised
- Dec 2021
Total raised
- Undisclosed
Investors
- 1
About iBiOME
Founded in 2021 and based in Hefei, China, iBiOME operates as a pharmaceutical company that focuses on Enterobacter drugs. The R&D team consists of scientists from universities such as Yale University, Harvard Medical School, and University of Science and Technology of China. Richard Flavell, one of the members of iBiOME's consultant team, is the professor of Yale University and the founder of Yale Department of Immunology. iBiOME's main business is the development of intestinal bacteria drugs, and the immunotherapy of human intestinal microorganisms. It has 4 core platforms, which are bacterial library and editing platform, process development platform, precise detection platform, and functional screening platform. Its pipeline with include Immue metabolismIBOBO1 and DescriptionIBN101. It also develops clinical treatment solutions, such as metabolic diseases, antitumor, inflammatory bowel disease, autoimmune diseases.
Who invested in iBiOME
1 investor across 1 round
See all investors in iBiOME
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Dec 2, 2021
Amount
Undisclosed
Investors
Questions about iBiOME
Who invested in iBiOME?
iBiOME has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iBiOME raised?
iBiOME has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did iBiOME last raise money?
iBiOME's most recent round on record is a Angel, in Dec 2021.
What does iBiOME do?
Founded in 2021 and based in Hefei, China, iBiOME operates as a pharmaceutical company that focuses on Enterobacter drugs.
Where is iBiOME headquartered?
iBiOME is headquartered in Hefei, China.
Which VCs invest in companies like iBiOME?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at iBiOME's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like iBiOME? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.